Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.

By M. Vodyanik, Jack A. Bork, James A. Thomson, I. Slukvin. Blood, 2005

633 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Embryonic stem cell differentiation: emergence of a new era in biology and medicine. (2005, background): “The hematopoietic potential of hES cells has been recently extended to include the lymphoid lineages, with the observation that cells expressing B-cell markers develop from CD34 cells following extensive culture on stromal cells (Vodyanik et al. 2005).”
Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. (2008, methodology): “Analysis of cell surface phenotypes revealed progression from populations that expressed KDR, CD31, and CD34 to those that also expressed CD45, a marker found on fetal and adult hematopoietic cells (Kennedy et al., 2007; Vodyanik et al., 2005; Woll et al., 2007).”